THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

OAKTREE CAPITAL MANAGEMENT LP's Holding History (CIK: 0000949509)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 6,206,000 Value ($000) $5,715 Avg Close — Range —
Q1 2022
Shares 7,509,000 Value ($000) $7,106 Avg Close — Range —
Q4 2021
Shares 7,509,000 Value ($000) $7,287 Avg Close — Range —
Q2 2021
Shares 6,246,000 Value ($000) $5,949 Avg Close — Range —
Q1 2021
Shares 6,543,000 Value ($000) $6,657 Avg Close — Range —